GenMark Q1 Revenues Jump on MDx System Placements | GenomeWeb

NEW YORK (GenomeWeb) – GenMark Diagnostics reported after the close of the market on Tuesday a 28 percent rise in first quarter revenues, an increase helped by the placement of 22 of its XT-8 molecular diagnostic systems during the period.

For the three-month period ended March 31, GenMark's revenues rose to $10.1 million from $7.9 million in the same period a year earlier, in line with the average Wall Street estimate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.